This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boyadzhyan, B. Articles by Hill, C. S. Search for Related Content PubMed PubMed Citation Articles by Boyadzhyan, B. Articles by Hill, C. S.

Comparison of the APTIMA CT and GC Assays with the APTIMA Combo 2 Assay, the Abbott LCx Assay, and Direct Fluorescent-Antibody and Culture Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Specialty Laboratories, Inc., Santa Monica,¹ Gen-Probe Incorporated, San Diego, California²

Received 26 November 2003/ Returned for modification 6 January 2004/ Accepted 6 April 2004

The Gen-Probe APTIMA Combo 2 (AC2) is a Food and Drug Administration-cleared nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae from urine and urogenital swab specimens. The Centers for Disease Control and Prevention have recommended confirmation of positive NAAT results in low-prevalence populations. APTIMA CT (ACT) and APTIMA GC (AGC) are two discrete NAATs for C. trachomatis and N. gonorrhoeae detection that are suitable for confirming AC2-positive results because they target different nucleic acid sequences. Our objective was to determine if ACT and AGC could be used as confirmatory tests for AC2 and to correlate the APTIMA assays with culture, direct fluorescent-antibody (DFA), and LCx CT and GC assays. Urine and swab specimens (1,304) were initially tested with either culture, DFA, or LCx, followed by AC2. A subset (675) was then tested with ACT and AGC. There was absolute concordance between ACT-AGC and AC2. LCx did not detect 1 of 14 AC2-ACT- and 1 of 6 AC2-AGC-positive urine samples, and it yielded one C. trachomatis- and one N. gonorrhoeae-positive swab result that were not detected by AC2 and ACT-AGC. Culture failed to detect 5 of 20 AC2-ACT and 3 of 4 AC2-AGC positives, and DFA missed 4 of 4 AC2-ACT positives. Thus, ACT and AGC relative sensitivity compared to that of AC2 was 100%. All APTIMA assays detected more confirmed positive results than culture, DFA, and LCx. The performance of APTIMA assays was not altered by the use of various swab types and by long-term storage of specimens. All APTIMA assays are highly sensitive and rapid. ACT and AGC can be recommended for confirmation of positive results from other NAATs, such as AC2 and LCx.

This article has been cited by other articles:

• Munson, E., Boyd, V., Czarnecka, J., Griep, J., Lund, B., Schaal, N., Hryciuk, J. E. (2007). Evaluation of Gen-Probe APTIMA-Based Neisseria gonorrhoeae and Chlamydia trachomatis Confirmatory Testing in a Metropolitan Setting of High Disease Prevalence. J. Clin. Microbiol. 45: 2793-2797 [Abstract] [Full Text]  
• Ryan, C., Kudesia, G., McIntyre, S., Davies, S., Zadik, P., Kinghorn, G. R, Bignell, C J (2007). BD ProbeTec ET assay for the diagnosis of gonorrhoea in a high-risk population: a protocol for replacing traditional microscopy and culture techniques. Sex. Transm. Infect. 83: 175-179 [Abstract] [Full Text]  
• Peeling, R W (2006). Testing for sexually transmitted infections: a brave new world?. Sex. Transm. Infect. 82: 425-430 [Full Text]  
• Lum, G., Garland, S. M., Tabrizi, S., Harnett, G., Smith, D. W., Sloots, T. P., Whiley, D. M., Tapsall, J. W., Lowe, P., O'Loughlin, P., Bartley, P. B., Vohra, R., Evans, K., White, M. (2006). Supplemental Testing Is Still Required in Australia for Samples Positive for Neisseria gonorrhoeae by Nucleic Acid Detection Tests.. J. Clin. Microbiol. 44: 4292-4294 [Full Text]  
• Lowe, P., O'Loughlin, P., Evans, K., White, M., Bartley, P. B., Vohra, R. (2006). Comparison of the Gen-Probe APTIMA Combo 2 Assay to the AMPLICOR CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples from Australian Men and Women.. J. Clin. Microbiol. 44: 2619-2621 [Abstract] [Full Text]  
• Chernesky, M., Castriciano, S., Jang, D., Smieja, M. (2006). Use of Flocked Swabs and a Universal Transport Medium To Enhance Molecular Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.. J. Clin. Microbiol. 44: 1084-1086 [Abstract] [Full Text]  
• Chernesky, M., Jang, D., Luinstra, K., Chong, S., Smieja, M., Cai, W., Hayhoe, B., Portillo, E., MacRitchie, C., Main, C., Ewert, R. (2006). High Analytical Sensitivity and Low Rates of Inhibition May Contribute to Detection of Chlamydia trachomatis in Significantly More Women by the APTIMA Combo 2 Assay. J. Clin. Microbiol. 44: 400-405 [Abstract] [Full Text]  
• Whiley, D. M., Tapsall, J. W., Sloots, T. P. (2006). Nucleic Acid Amplification Testing for Neisseria gonorrhoeae: An Ongoing Challenge. J. Mol. Diagn. 8: 3-15 [Abstract] [Full Text]  
• Jespersen, D. J., Flatten, K. S., Jones, M. F., Smith, T. F. (2005). Prospective Comparison of Cell Cultures and Nucleic Acid Amplification Tests for Laboratory Diagnosis of Chlamydia trachomatis Infections. J. Clin. Microbiol. 43: 5324-5326 [Abstract] [Full Text]  
• Chalker, V. J., Vaughan, H., Patel, P., Rossouw, A., Seyedzadeh, H., Gerrard, K., James, V. L. A. (2005). External Quality Assessment for Detection of Chlamydia trachomatis. J. Clin. Microbiol. 43: 1341-1347 [Abstract] [Full Text]  
• Marrazzo, J. M., Johnson, R. E., Green, T. A., Stamm, W. E., Schachter, J., Bolan, G., Hook, E. W. III, Jones, R. B., Martin, D. H., St. Louis, M. E., Black, C. M. (2005). Impact of Patient Characteristics on Performance of Nucleic Acid Amplification Tests and DNA Probe for Detection of Chlamydia trachomatis in Women with Genital Infections. J. Clin. Microbiol. 43: 577-584 [Abstract] [Full Text]